Literature DB >> 16010857

Developmental pharmacology and toxicology: biotransformation of drugs and other xenobiotics during postnatal development.

Wolfgang Klinger1.   

Abstract

The following conclusions can be drawn: Depending on reaction type, species (strain), organ (tissue) and sex (in rats and mice) both phase I and phase II ractions show developmental patterns with maximum activities in juvenile or young adult animals. In man drug disposition in newborns is also generally much lower than in children and young adults. Mammals with long gestation periods are born with considerable activities and adult values are reached earlier than in animals with short gestation periods. Highest activities (with very few exceptions) are observed in liver postnatally. With increasing age, in all laboratory animals and in man, a decline of biotransformation capacity is observed. Most of these reactions are inducible by inducers of the phenobarbital-, 3-methylcholanthrene- and tetrachlorodibenzo-p-dioxine-, steroid- or alcohol-type. Inducibility also depends on reaction type, species (strain), organ (tissue) and sex (in rats and mice). Inducibility begins in the earliest embryonic stage and reaches high rates in species with long gestation periods before birth, and at or after birth in species with short gestation periods. The beginning of high inducibility depends also on inducer types and the induced parameter. Inducible reactions can be increased in immature as well as in very old animals up to or above the level of adult animals. Isozymes may show different developmental patterns and inducibilities. Development and induction of isozymes catalyzing different reactions can be triggered in clusters. There is increasing evidence that basic biotransformation activities as well as their inducibilities by foreign compounds are essentially influenced by a kind of temporal genetic control during the whole life span. When we compared different monooxygenase reactions and their inducibility (Klinger et al., 1968) both the presence of P450 isozymes and their different inducibility as well as their different developmental pattern became evident, the direct proof of which was given 10 years later by the Nebert group (Atlas et al. 1977). Functional heterogeneity was demonstrated by differential development and inducibility by glucocorticoids also for UDP-glucuronosyl transferase (Wishart, 1978): in the rat the increased fetal glucocorticoid activity between days 17 and 20 of gestation triggers the surge to adult or higher than adult activities. This cluster of the so-called late fetal glucuronyltransferase group is distinctly different from the neonatal or postnatal cluster with peak values after birth and a pronounced inducibility by 3-methylcholanthrene, but not by steroids. These different transferase clusters can be differentiated by different substrates, too. To get an overview on the postnatal development of the most important phase I and phase II reactions and also for the heme biosynthetic pathway as a prerequisite for the P450 synthesis, a compilation of literature data similar to a score was constructed with the aim to recognize parallel developments, possible common control and regulation mechanisms, cp. Klinger et al. 1987, cp. also Figs. 1-3. Evidently different developmental patterns can be observed, direct connections or dependencies cannot be detected. Thus different concentrations resp. activities of different P450 forms during ontogenetic development are influenced by many factors on the transscriptional and posttransscriptional level. Reviews on concepts and therories of development and aging have been published by several authors respectively editors (cp. Klinger, 1996). But there is no convincing concept or proof on the molecular-biological basis of an internal clock which regulates and controls individual development, aging and death.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16010857     DOI: 10.1007/BF03226403

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  60 in total

1.  Functional heterogeneity of UDP-glucuronosyltransferase as indicated by its differential development and inducibility by glucocorticoids. Demonstration of two groups within the enzyme's activity towards twelve substrates.

Authors:  G J Wishart
Journal:  Biochem J       Date:  1978-08-15       Impact factor: 3.857

2.  VARIATION IN THE ACTIVITY OF LIVER MICROSOMAL DRUG-METABOLIZING ENZYMES IN RATS IN RELATION TO THE AGE.

Authors:  R KATO; P VASSANELLI; G FRONTINO; E CHIESARA
Journal:  Biochem Pharmacol       Date:  1964-07       Impact factor: 5.858

3.  [The activity of N- and O-demethylase in the human liver].

Authors:  E Ackermann; I Heinrich
Journal:  Biochem Pharmacol       Date:  1970-02       Impact factor: 5.858

Review 4.  Developmental pharmacology.

Authors:  B L Mirkin
Journal:  Annu Rev Pharmacol       Date:  1970       Impact factor: 13.820

Review 5.  Cytochrome P450: evolution and functional diversity.

Authors:  D W Nebert; R A McKinnon
Journal:  Prog Liver Dis       Date:  1994

Review 6.  Pharmacology of the developing digestive system.

Authors:  W Klinger
Journal:  Pharmacol Ther       Date:  1983       Impact factor: 12.310

Review 7.  Biotransformation of xenobiotics in the fetus.

Authors:  O Pelkonen
Journal:  Pharmacol Ther       Date:  1980       Impact factor: 12.310

Review 8.  P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature.

Authors:  D R Nelson; L Koymans; T Kamataki; J J Stegeman; R Feyereisen; D J Waxman; M R Waterman; O Gotoh; M J Coon; R W Estabrook; I C Gunsalus; D W Nebert
Journal:  Pharmacogenetics       Date:  1996-02

9.  Increased response of cytochrome P-450 dependent biotransformation reactions in rat liver to repeated administration of inducers.

Authors:  U Kleeberg; M Sommer; W Klinger
Journal:  Arch Toxicol Suppl       Date:  1985

10.  In vivo and in vitro inhibition of 3-methylcholanthrene-induced aryl hydrocarbon hydroxylase activity in rat liver by actinomycin D and 7,8-benzoflavone.

Authors:  U Kleeberg; G Grohmann; R Volkmann; H Steinert; W Klinger
Journal:  Pol J Pharmacol Pharm       Date:  1979 Nov-Dec
View more
  8 in total

1.  Nicotine pharmacokinetics in rats is altered as a function of age, impacting the interpretation of animal model data.

Authors:  Evelyn L Craig; Bin Zhao; Jason Z Cui; Maria Novalen; Sharon Miksys; Rachel F Tyndale
Journal:  Drug Metab Dispos       Date:  2014-06-30       Impact factor: 3.922

Review 2.  Biological determinants impact the neurovascular toxicity of nicotine and tobacco smoke: A pharmacokinetic and pharmacodynamics perspective.

Authors:  Sabrina Rahman Archie; Sejal Sharma; Elizabeth Burks; Thomas Abbruscato
Journal:  Neurotoxicology       Date:  2022-02-09       Impact factor: 4.294

3.  Age-related differences in the disposition of nicotine and metabolites in rat brain and plasma.

Authors:  Paula L Vieira-Brock; David M Andrenyak; Shannon M Nielsen; Annette E Fleckenstein; Diana G Wilkins
Journal:  Nicotine Tob Res       Date:  2013-06-04       Impact factor: 4.244

4.  Acid Sphingomyelinase Inhibition Stabilizes Hepatic Ceramide Content and Improves Hepatic Biotransformation Capacity in a Murine Model of Polymicrobial Sepsis.

Authors:  Ha-Yeun Chung; C Julius Witt; Jorge Hurtado-Oliveros; Jonathan Wickel; Markus H Gräler; Amelie Lupp; Ralf A Claus
Journal:  Int J Mol Sci       Date:  2018-10-15       Impact factor: 5.923

5.  Nutrigenomics-Associated Impacts of Nutrients on Genes and Enzymes With Special Consideration of Aromatase.

Authors:  Helena Jenzer; Leila Sadeghi-Reeves
Journal:  Front Nutr       Date:  2020-04-09

Review 6.  Epigallocatechin-3-Gallate Toxicity in Children: A Potential and Current Toxicological Event in the Differential Diagnosis With Virus-Triggered Fulminant Hepatic Failure.

Authors:  Consolato M Sergi
Journal:  Front Pharmacol       Date:  2020-01-29       Impact factor: 5.810

7.  Age-related changes in hepatic activity and expression of detoxification enzymes in male rats.

Authors:  Erika Vyskočilová; Barbora Szotáková; Lenka Skálová; Hana Bártíková; Jitka Hlaváčová; Iva Boušová
Journal:  Biomed Res Int       Date:  2013-07-22       Impact factor: 3.411

8.  Lipid peroxidation, detoxification capacity, and genome damage in mice after transplacental exposure to pharmaceutical drugs.

Authors:  D Markovic; J Katic; R Stojkovic; S Borovic; N Zarkovic; A Fucic
Journal:  Braz J Med Biol Res       Date:  2013-12-10       Impact factor: 2.590

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.